ABCC1 and acute lymphoblastic leukemia: These findings are likely to be of clinical significance since Matrigel/β1 integrin protects T-ALL blasts from doxorubicin (Fig. 2) and that ABCC1 is expressed in human T-ALL cells and its activity correlates with poor prognosis36,37.